Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Impact of NUDT15 polymorphisms on thiopurines-induced myelotoxicity and thiopurines tolerance dose

作者:Dandan Yin, Xuyang Xia, Junlong Zhang, Shouyue Zhang, Fei Liao, Ge Zhang, Yan Zhang, Qianqian Hou, Xue Yang, Hong Wang, Zhigui Ma, Heyao Wang, Yiping Zhu, Wei Zhang, Yuelan Wang, Bo Liu, Lanlan Wang, Heng Xu, Yang Shu · 发表于:Oncotarget · 年份:2017 · DOI:10.18632/oncotarget.14594 · 被引用次数:44 · 研究领域:Acute Lymphoblastic Leukemia research、Renal Transplantation Outcomes and Treatments、Biochemical and Molecular Research

// Dandan Yin 1, * , Xuyang Xia 1, * , Junlong Zhang 2, * , Shouyue Zhang 1, * , Fei Liao 1 , Ge Zhang 3 , Yan Zhang 4 , Qianqian Hou 1 , Xue Yang 5 , Hong Wang 5 , Zhigui Ma 3 , Heyao Wang 6 , Yiping Zhu 3 , Wei Zhang 7 , Yuelan Wang 1 , Bo Liu 1 , Lanlan Wang 2 , Heng Xu 1, 2 , Yang Shu 1 1 Department of Laboratory Medicine, National Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China 2 Department of Laboratory Medicine/Research Center of Clinical Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China 3 Department of Pediatric Hematology/Oncology, West China Second Hospital Sichuan University, Chengdu, Sichuan, China 4 Department of Thoracic Oncology, Cancer Center, National Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China 5 Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN, USA 6 Department of Precision Medicine, China-Japan Friendship Hospital, Beijing, China 7 Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Xiangya Hospital, Central South University, Changsha, China * These authors contributed equally to this work Correspondence to: Lanlan Wang, email: wangll87@126.com Heng Xu, email: xuheng81916@scu.edu.cn Yang Shu, email: shuyang1986@gmail.com Keywords: meta-analysis, NU...